Costs and outcomes of recombinant human bone morphogenetic protein-2 usage in single-level posterior or transforaminal lumbar interbody fusion in a propensity score-matched national, retrospective cohort
Costs and outcomes of recombinant human bone morphogenetic protein-2 usage in single-level posterior or transforaminal lumbar interbody fusion in a propensity score-matched national, retrospective cohort. // The Spine Journal. – URL: https://www.sciencedirect.com/science/article/pii/S1529943026006698?dgcid=rss_sd_all
Costs and outcomes of recombinant human bone morphogenetic protein-2 usage in single-level posterior or transforaminal lumbar interbody fusion in a propensity score-matched national, retrospective cohort. The Spine Journal. https://www.sciencedirect.com/science/article/pii/S1529943026006698?dgcid=rss_sd_all
“Costs and outcomes of recombinant human bone morphogenetic protein-2 usage in single-level posterior or transforaminal lumbar interbody fusion in a propensity score-matched national, retrospective cohort.” The Spine Journal.
@article{article69364,
title = {Costs and outcomes of recombinant human bone morphogenetic protein-2 usage in single-level posterior or transforaminal lumbar interbody fusion in a propensity score-matched national, retrospective cohort},
journal = {The Spine Journal},
url = {https://www.sciencedirect.com/science/article/pii/S1529943026006698?dgcid=rss_sd_all}
}
ABSTRACT Objectives The aim of this study was to determine whether certain cephalometric findings can predict the future need for orthognathic surgery (OS) in cleft lip (CL), cleft palate (CP), unilateral cleft lip and palate (UCLP),...